New York S 7342: Prohibits the administration of COVID-19 mRNA vaccinations

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S07342 Summary:

BILL NOS07342 

&nbsp

SAME ASSAME AS A04798

&nbsp

SPONSORWEIK

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

&nbsp

Prohibits the administration of COVID-19 mRNA vaccinations; requires the department of health to conduct a study and make recommendations on the benefits and risks of the administration of such vaccines; requires a self-controlled case series to be completed; makes related provisions.

Go to top S07342 Actions:

BILL NOS07342 

&nbsp

04/10/2025REFERRED TO HEALTH

01/07/2026REFERRED TO HEALTH

Go to topS07342 Committee&nbspVotes:

Go to topS07342 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS07342 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 7342

 2025-2026 Regular Sessions

 IN SENATE

 April 10, 2025
 ___________

 Introduced by Sen. WEIK -- read twice and ordered printed, and when
 printed to be committed to the Committee on Health

 AN ACT in relation to prohibiting the administration of COVID-19 mRNA
 vaccinations

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Notwithstanding any other provision of law to the contrary,
 2 the administration of COVID-19 mRNA vaccinations is prohibited until the
 3 department of health analyzes any existing data and concludes that the
 4 benefits of such vaccine outweigh the risks.
 5 § 2. The department of health shall conduct a study and make recommen-
 6 dations on the benefits and risks of the administration of COVID-19 mRNA
 7 vaccinations. Such analysis shall include, but not be limited to, a
 8 self-controlled case series which shall be completed within one year of
 9 the effective date of this act. Only after the conclusion of such analy-
 10 sis the department determines that the administration of COVID-19 mRNA
 11 vaccinations are safe may the use of such vaccine continue.
 12 § 3. This act shall take effect immediately.

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD07250-01-5

Go to top 

• 

 Sitemap 

 Request Information 

 Directions and Maps